secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2026-06-24T12:30:17+00:00
Accession:  0001411690-26-000040
Event type: leadership
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics hires Alex Hastie, Ph.D., as Chief Scientific Officer effective July 20, 2026
--------------------------------------------------------------------------------

- Hastie returns after 14 years at Bionano as a foundational figure in optical genome mapping (OGM) technology.
- He will lead global scientific strategy, innovation roadmap, and research initiatives for genome analysis.
- Quotes from experts at Radboud, Johns Hopkins, MD Anderson, and Dartmouth welcome his return as 'Mr. OGM'.
- Appointment underscores Bionano's commitment to advancing OGM for clinical and research applications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000040/0001411690-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000040/bngo-20260624.htm
  HTML page:      https://secwatch.observer/filing/0001411690-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer